EyePoint Pharmaceuticals, Inc. (EYPT)

EyePoint Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	79.83	281.26	95.63	178.59	44.91	22.21
Short-Term Investments	173.96	49.79	48.93	32.97	-	-
Cash & Short-Term Investments	253.79	331.05	144.56	211.56	44.91	22.21
Cash Growth	86.60%	129.00%	-31.67%	371.08%	102.17%	-50.92%
Receivables	0.38	0.81	15.5	18.35	9.45	11.37
Inventory	2.81	3.91	2.89	3.62	5.34	2.14
Prepaid Expenses	10.27	8.03	9.08	4.22	3.42	6
Other Current Assets	1.3	1.01	0.78	-	-	-
Total Current Assets	268.55	344.8	172.81	237.75	63.12	41.72
Property, Plant & Equipment	29.8	10.23	7.4	2.73	3.24	3.44
Other Intangible Assets	-	-	-	22.75	25.21	27.67
Other Long-Term Assets	2.57	0.15	0.15	0.15	0.15	0.15
Total Assets	300.92	355.18	180.36	263.37	91.72	72.97
Accounts Payable	7.34	6.5	5.92	7.39	4.81	4.19
Accrued Expenses	13.89	16.76	15.34	11.45	7.34	4.94
Short-Term Debt	-	-	10.48	-	-	-
Current Portion of Leases	1.19	0.56	0.54	0.78	0.69	0.48
Current Unearned Revenue	26	38.59	1.21	1.07	0.95	0.02
Other Current Liabilities	0.38	0.84	1.05	2.97	1.11	1.89
Total Current Liabilities	48.79	63.26	34.54	23.66	14.89	11.52
Long-Term Debt	-	-	29.31	36.56	37.98	47.22
Long-Term Leases	21.92	4.91	5.98	1.9	2.4	2.9
Long-Term Unearned Revenue	11.23	20.69	13.56	14.56	15.62	-
Other Long-Term Liabilities	0.23	-	0.6	2.32	2.29	3
Total Liabilities	82.18	88.86	83.99	78.99	73.18	64.64
Common Stock	0.05	0.05	0.03	0.03	0.02	0.01
Additional Paid-In Capital	1,049	1,008	766.9	752.6	528.36	472.77
Retained Earnings	-831.62	-742.15	-671.35	-569.1	-510.68	-465.29
Comprehensive Income & Other	1.17	0.86	0.79	0.84	0.84	0.84
Shareholders' Equity	218.73	266.32	96.37	184.38	18.54	8.33
Total Liabilities & Equity	300.92	355.18	180.36	263.37	91.72	72.97
Total Debt	23.11	5.47	46.31	39.24	41.07	50.6
Net Cash (Debt)	230.68	325.58	98.25	172.32	3.84	-28.39
Net Cash Growth	77.76%	231.38%	-42.98%	4382.78%	-	-
Net Cash Per Share	4.55	8.37	2.63	5.99	0.30	-2.72
Filing Date Shares Outstanding	68.25	49.83	34.3	34.04	28.74	12.47
Total Common Shares Outstanding	53.52	49.04	34.08	33.91	18.14	10.94
Working Capital	219.76	281.54	138.27	214.09	48.23	30.2
Book Value Per Share	4.09	5.43	2.83	5.44	1.02	0.76
Tangible Book Value	218.73	266.32	96.37	161.63	-6.67	-19.34
Tangible Book Value Per Share	4.09	5.43	2.83	4.77	-0.37	-1.77
Construction In Progress	-	3.73	-	-	-	-
Leasehold Improvements	-	1.01	1.01	0.26	0.26	0.1

Source: S&P Capital IQ. Standard template. Financial Sources.